BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Badrinath N, Yoo SY. Recent Advances in Cancer Stem Cell-Targeted Immunotherapy. Cancers (Basel) 2019;11:E310. [PMID: 30841635 DOI: 10.3390/cancers11030310] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Correia C, Weiskittel TM, Ung CY, Villasboas Bisneto JC, Billadeau DD, Kaufmann SH, Li H. Uncovering Pharmacological Opportunities for Cancer Stem Cells—A Systems Biology View. Front Cell Dev Biol 2022;10:752326. [DOI: 10.3389/fcell.2022.752326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Amalinei C, Grigoraș A, Lozneanu L, Căruntu I, Giușcă S, Balan RA. The Interplay between Tumour Microenvironment Components in Malignant Melanoma. Medicina 2022;58:365. [DOI: 10.3390/medicina58030365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mohseninia A, Dehghani P, Bargahi A, Rad-Malekshahi M, Rahimikian R, Movahed A, Reza Farzaneh M, Mohammadi M. Harnessing self-assembling peptide nanofibers toprime robust tumor-specific CD8 T cell responses in mice. Int Immunopharmacol 2022;104:108522. [PMID: 35032825 DOI: 10.1016/j.intimp.2022.108522] [Reference Citation Analysis]
4 Wilczyński JR. Cancer Stem Cells: An Ever-Hiding Foe. Experientia Supplementum 2022. [DOI: 10.1007/978-3-030-91311-3_8] [Reference Citation Analysis]
5 Mukherjee S, Baidya A, Barik S. New Approaches in Cancer Research: Stem Cell Research, Translational Research, Immunotherapy, and Others. Cancer Diagnostics and Therapeutics 2022. [DOI: 10.1007/978-981-16-4752-9_16] [Reference Citation Analysis]
6 Amalinei C, Balan RA, Grigoras A, Lozneanu L, Avadanei ER, Giusca SE, Caruntu ID. Implications of ROS in Cancer Stem Cells Mechanism of Action. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects 2022. [DOI: 10.1007/978-981-15-9411-3_113] [Reference Citation Analysis]
7 Della Sala G, Pacelli C, Agriesti F, Laurenzana I, Tucci F, Tamma M, Capitanio N, Piccoli C. Unveiling Metabolic Vulnerability and Plasticity of Human Osteosarcoma Stem and Differentiated Cells to Improve Cancer Therapy. Biomedicines 2021;10:28. [PMID: 35052705 DOI: 10.3390/biomedicines10010028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cui X, Liu R, Duan L, Cao D, Zhang Q, Zhang A. CAR-T therapy: Prospects in targeting cancer stem cells. J Cell Mol Med 2021;25:9891-904. [PMID: 34585512 DOI: 10.1111/jcmm.16939] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
9 Li C, Zhang J, Yang X, Hu C, Chu T, Zhong R, Shen Y, Hu F, Pan F, Xu J, Lu J, Zheng X, Zhang H, Nie W, Han B, Zhang X. hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527. Cell Death Dis 2021;12:807. [PMID: 34433810 DOI: 10.1038/s41419-021-04095-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
10 Mokhtari RB, Sambi M, Qorri B, Baluch N, Ashayeri N, Kumar S, Cheng HM, Yeger H, Das B, Szewczuk MR. The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy. Cancers (Basel) 2021;13:3596. [PMID: 34298809 DOI: 10.3390/cancers13143596] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Esmaeili SA, Sahranavard S, Salehi A, Bagheri V. Selectively targeting cancer stem cells: Current and novel therapeutic strategies and approaches in the effective eradication of cancer. IUBMB Life 2021;73:1045-59. [PMID: 34184810 DOI: 10.1002/iub.2524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Okwundu N, Grossman D, Hu-Lieskovan S, Grossmann KF, Swami U. The dark side of immunotherapy. Ann Transl Med 2021;9:1041. [PMID: 34277841 DOI: 10.21037/atm-20-4750] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
13 Schwerdtfeger M, Desiderio V, Kobold S, Regad T, Zappavigna S, Caraglia M. Long non-coding RNAs in cancer stem cells. Transl Oncol 2021;14:101134. [PMID: 34051619 DOI: 10.1016/j.tranon.2021.101134] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
14 Naseri M, Zöller M, Hadjati J, Ghods R, Ranaei Pirmardan E, Kiani J, Eini L, Bozorgmehr M, Madjd Z. Dendritic cells loaded with exosomes derived from cancer stem cell-enriched spheroids as a potential immunotherapeutic option. J Cell Mol Med 2021;25:3312-26. [PMID: 33634564 DOI: 10.1111/jcmm.16401] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
15 Marzagalli M, Fontana F, Raimondi M, Limonta P. Cancer Stem Cells-Key Players in Tumor Relapse. Cancers (Basel) 2021;13:376. [PMID: 33498502 DOI: 10.3390/cancers13030376] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 23.0] [Reference Citation Analysis]
16 Amalinei C, Balan RA, Grigoras A, Lozneanu L, Avadanei ER, Giusca SE, Caruntu ID. Implications of ROS in Cancer Stem Cells Mechanism of Action. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects 2021. [DOI: 10.1007/978-981-15-4501-6_113-1] [Reference Citation Analysis]
17 Acikgoz E, Sati L, Soner BC, Oktem G. NK cells in prostate cancer. Successes and Challenges of NK Immunotherapy 2021. [DOI: 10.1016/b978-0-12-824375-6.00019-9] [Reference Citation Analysis]
18 Sangsuwannukul T, Supimon K, Sujjitjoon J, Phanthaphol N, Chieochansin T, Poungvarin N, Wongkham S, Junking M, Yenchitsomanus PT. Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells targeting CD133 against cholangiocarcinoma cells. Int Immunopharmacol 2020;89:107069. [PMID: 33242709 DOI: 10.1016/j.intimp.2020.107069] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
19 Cao J, Bhatnagar S, Wang J, Qi X, Prabha S, Panyam J. Cancer stem cells and strategies for targeted drug delivery. Drug Deliv Transl Res 2021;11:1779-805. [PMID: 33095384 DOI: 10.1007/s13346-020-00863-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Paul MK, Marati VR, Sambandam Y, Queimado L, Chaudhuri G, Ramachandran I, Kumaran RI. Targeting Therapies for Cancer Stem Cells. In: Pathak S, Banerjee A, editors. Cancer Stem Cells: New Horizons in Cancer Therapies. Singapore: Springer; 2020. pp. 273-312. [DOI: 10.1007/978-981-15-5120-8_16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
21 Ponterio E, De Maria R, Haas TL. Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture. Front Immunol 2020;11:565631. [PMID: 33101285 DOI: 10.3389/fimmu.2020.565631] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
22 Jo Y, Ali LA, Shim JA, Lee BH, Hong C. Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield. Cancers (Basel) 2020;12:E2087. [PMID: 32731404 DOI: 10.3390/cancers12082087] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
23 Kula A, Dawidowicz M, Kiczmer P, Prawdzic Seńkowska A, Świętochowska E. The role of genetic polymorphism within PD-L1 gene in cancer. Review. Exp Mol Pathol 2020;116:104494. [PMID: 32679050 DOI: 10.1016/j.yexmp.2020.104494] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
24 Pádua D, Figueira P, Ribeiro I, Almeida R, Mesquita P. The Relevance of Transcription Factors in Gastric and Colorectal Cancer Stem Cells Identification and Eradication. Front Cell Dev Biol 2020;8:442. [PMID: 32626705 DOI: 10.3389/fcell.2020.00442] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
25 Tanabe S, Quader S, Cabral H, Ono R. Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies. Front Pharmacol 2020;11:904. [PMID: 32625096 DOI: 10.3389/fphar.2020.00904] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 29.0] [Reference Citation Analysis]
26 Alhabbab RY. Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells. Front Genet 2020;11:312. [PMID: 32391048 DOI: 10.3389/fgene.2020.00312] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
27 Raniszewska A, Kwiecień I, Sokołowski R, Rutkowska E, Domagała-Kulawik J. Immunomodulatory Molecules On Lung Cancer Stem Cells From Lymph Nodes Aspirates. Cancers (Basel) 2020;12:E838. [PMID: 32244422 DOI: 10.3390/cancers12040838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
28 Lu L, Du H, Huang H, Wang C, Wang P, Zha Z, Wu Y, Liu X, Weng C, Fang X, Li B, Mao H, Wang L, Guan M, Liu G. CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells. Int J Med Sci 2020;17:912-20. [PMID: 32308544 DOI: 10.7150/ijms.40864] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
29 Padmanabhan R, Kheraldine HS, Meskin N, Vranic S, Al Moustafa AE. Crosstalk between HER2 and PD-1/PD-L1 in Breast Cancer: From Clinical Applications to Mathematical Models. Cancers (Basel) 2020;12:E636. [PMID: 32164163 DOI: 10.3390/cancers12030636] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
30 Jiang G, Chen H, Huang J, Song Q, Chen Y, Gu X, Jiang Z, Huang Y, Lin Y, Feng J, Jiang J, Bao Y, Zheng G, Chen J, Chen H, Gao X. Tailored Lipoprotein-Like miRNA Delivery Nanostructure Suppresses Glioma Stemness and Drug Resistance through Receptor-Stimulated Macropinocytosis. Adv Sci (Weinh) 2020;7:1903290. [PMID: 32154087 DOI: 10.1002/advs.201903290] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
31 Abou Khouzam R, Goutham HV, Zaarour RF, Chamseddine AN, Francis A, Buart S, Terry S, Chouaib S. Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy. Semin Cancer Biol 2020;65:140-54. [PMID: 31927131 DOI: 10.1016/j.semcancer.2020.01.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 16.0] [Reference Citation Analysis]
32 Bagley SJ, O’rourke DM. Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions. Pharmacology & Therapeutics 2020;205:107419. [DOI: 10.1016/j.pharmthera.2019.107419] [Cited by in Crossref: 49] [Cited by in F6Publishing: 59] [Article Influence: 24.5] [Reference Citation Analysis]
33 Zhang S, Yang Z, Qi F. Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy. Mol Biol Rep 2020;47:1435-43. [PMID: 31838656 DOI: 10.1007/s11033-019-05227-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
34 Yoo SY, Badrinath N, Lee HL, Heo J, Kang DH. A Cancer-Favoring, Engineered Vaccinia Virus for Cholangiocarcinoma. Cancers (Basel) 2019;11:E1667. [PMID: 31717883 DOI: 10.3390/cancers11111667] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
35 Zhang Y, Fang Z, Li R, Huang X, Liu Q. Design of Outer Membrane Vesicles as Cancer Vaccines: A New Toolkit for Cancer Therapy. Cancers (Basel) 2019;11:E1314. [PMID: 31500086 DOI: 10.3390/cancers11091314] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
36 Rodriguez-Aznar E, Wiesmüller L, Sainz B Jr, Hermann PC. EMT and Stemness-Key Players in Pancreatic Cancer Stem Cells. Cancers (Basel) 2019;11:E1136. [PMID: 31398893 DOI: 10.3390/cancers11081136] [Cited by in Crossref: 51] [Cited by in F6Publishing: 58] [Article Influence: 17.0] [Reference Citation Analysis]
37 Yuan Y, Yangmei Z, Rongrong S, Xiaowu L, Youwei Z, Sun S. Sotrastaurin attenuates the stemness of gastric cancer cells by targeting PKCδ. Biomed Pharmacother 2019;117:109165. [PMID: 31261030 DOI: 10.1016/j.biopha.2019.109165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]